Melatonin Inhibits EMT in Bladder Cancer by Targeting Autophagy
Open Access
Abstract
Melatonin, a naturally biosynthesized molecule secreted by the pineal gland, exhibits antitumor activities against several different types of cancer. The mechanisms of action of melatonin against tumor progression involve cellular apoptosis, antimetastatic activity, antioxidant and mutagenic effects, antiangiogenic activity, and the restoration of cancer immune surveillance. Melatonin has anticancer activity when administered alone or in combination with standard chemotherapeutic agents, with measurable improvements seen in the clinical endpoints of tumor regression and patient survival. However, scant clinical evidence supports the use of melatonin in bladder cancer treatment. Our study has found that melatonin treatment suppresses the bladder cancer cell migratory ability by inhibiting the epithelial-mesenchymal transition (EMT) process, which appears to be linked to melatonin-induced decreases in bladder cancer cell autophagy. Finally, an evaluation of in vivo melatonin-induced antitumor effects in an orthotopic animal model of bladder cancer indicated that melatonin treatment slightly prolonged the survival of tumor-bearing mice. Our study offers novel insights into the use of melatonin in bladder cancer treatment.Keywords
Funding Information
- Chi Mei Medical Cente (110-CM-FJU-04, CMU111-ASIA-04, CMU111-NSTC-04, CMU111-NSTC-03, DMR-112-146, MOST-109-2320-B-341-001)
- China Medical University (110-CM-FJU-04, CMU111-ASIA-04, CMU111-NSTC-04, CMU111-NSTC-03, DMR-112-146, MOST-109-2320-B-341-001)
- China Medical University Hospital (110-CM-FJU-04, CMU111-ASIA-04, CMU111-NSTC-04, CMU111-NSTC-03, DMR-112-146, MOST-109-2320-B-341-001)
- Ministry of Science and Technology (110-CM-FJU-04, CMU111-ASIA-04, CMU111-NSTC-04, CMU111-NSTC-03, DMR-112-146, MOST-109-2320-B-341-001)
This publication has 57 references indexed in Scilit:
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurrent Opinion in Immunology, 2012
- Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancerCancer and Metastasis Reviews, 2009
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- The role of autophagy in tumour development and cancer therapyExpert Reviews in Molecular Medicine, 2009
- Autophagy: process and functionGenes & Development, 2007
- Autophagy: from phenomenology to molecular understanding in less than a decadeNature Reviews Molecular Cell Biology, 2007
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005
- Carcinoma Invasion and Metastasis: A Role for Epithelial-Mesenchymal Transition?Cancer Research, 2005
- Growth Factor Regulation of Autophagy and Cell Survival in the Absence of ApoptosisCell, 2005